Tutorial 45: Intrathecal analgesics as we approach the new millennium

Pain Digest

Volumn 10, Issue 1, 2000, Pages 34-50

  Walia, Kulbir ^a   Mitchell, Veronica ^b   Staats, Peter S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ADENOSINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUPIVACAINE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIHYDROMORPHINE; FENTANYL; GLYCINE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE]; LIDOCAINE; LOCAL ANESTHETIC AGENT; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE; PETHIDINE; PROSTAGLANDIN SYNTHASE INHIBITOR; SEROTONIN; SOMATOSTATIN; SUBSTANCE P ANTAGONIST; SUFENTANIL; TETRACAINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; CLINICAL TRIAL; CONSTIPATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GENE THERAPY; HUMAN; IMPLANT; INFUSION PUMP; NAUSEA; NONHUMAN; PAIN; REVIEW; SEXUAL DYSFUNCTION; URINE INCONTINENCE; URINE RETENTION; VOMITING;

EID: 0034114340     PISSN: 09389016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Behar M, Magora F, Olshwang D: Epidural morphine in the treatment of pain. Lancet 1979;1:527-528
2. Coombs DW, Saunders RL, Gaylor MS: Continuous epidural analgesia via implanted morphine reservoir. Lancet 1981;2:425-426
3. Oakley J, Staats PS: Intraspinal infusion devices. In Raj PP (ed): Practical Management of Pain, ed 3. St. Louis, Mosby Year Book, 1999
4. Paice JA, Penn RD, Shott SD: Intraspinal morphine for chronic pain: A retrospective multicenter study. J Pain Symptom Manage 1996;11:71-80
5. Staats PS, Smith T, Coyne P et al: A multicenter, randomized controlled trial of intrathecal therapy vs. systemic therapy for chronic cancer pain. Presented at the 18th Annual Scientific Meeting of the American Pain Society, Ft. Lauderdale, FL, USA, October 1999
6. Maron J, Loeser JD: Spinal opioid infusions in the treatment of chronic pain of non-malignant origin. Clin J Pain 1996;12:174-179
7. Doleys DM, Dinoff BL, Page L et al: Sexual dysfunction and other side effects of intraspinal opiate use in the management of chronic non-cancer pain. AJPM 1998;8:5-11
8. Paice JA, Penn RD, Ryan WG: Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-131
9. Lubenow TR, Faber LP, McCarthy RJ et al: Post-thoracotomy pain management using continuous epidural analgesia in 1,324 patients. Ann Thorac Surg 1994;58:924-930
10. Shafer AL, Donnelly AJ: Management of postoperative pain by continuous epidural infusion of analgesics (published erratum appears in Clin Pharm 1991;10:824) (Review) Clin Pharm 1991;10:745-764
11. Rapp SE, Ready LB, Greer BE: Postoperative pain management in gynecology oncology patients utilizing epidural opiate analgesia and patient controlled analgesia. Gynecol Oncol 1989;35:341-344
12. Sjoberg M, Appelgren L, Einarsson S: Long term intrathecal morphine and bupivacaine in refractory cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand 1991;35:30-43
13. Hardy PAJ, Wells JCD: Continuous intrathecal lignocaine infusion analgesia: A case report of a nine-week spinal. Palliat Med 1989;3:23-25
14. Applegren L, Janson M, Nitescu P et al: Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain. Anesthesiology 1996;84:256-272
15. Krames ES, Lanning RM: Intrathecal infusional analgesia for non-malignant pain: Analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993;8:539-548
16. Onofrio BM, Yaksh TL: Long term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990;72:200-209
17. Ding DM, Yaksh TL: Differential right shifts in the dose response curve for intrathecal morphine and sufentanil as a function of stimulus intensity. Pain 1995;62:321-328
18. Van Dongen Robert TM, Crul BJP, Van Egmond J: Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long term intrathecal infusion in cancer patients. Clin J Pain 1999;15:166-172
19. Arbuckle JB, Docherty RJ: Expression of tetrodotoxin-resistant sodium channel in capsaicin-sensitive dorsal root ganglion neurons of adult rats. Neurosci Lett 1995;185:70-73
20. Akopian AJ, Sivilati L, Wood JN: A tetrodotoxin-resistant voltage gated channel expressed by sensory neurons. Lett Nature 1996;379: 257-262
21. Yaksh TL, Malmberg AB: Central pharmacology of nociceptive transmission. In Wall PD, Melzack R (eds): The Textbook of Pain, ed 3. New York, Churchill Livingstone, 1994, pp 165-200
22. Kristensen JD, Karlsten R, Gordh T: Laser doppler evaluation of spinal cord blood flow after intrathecal administration of an N-methyl D-aspartate antagonist in rats. Anesth Analg 1994;78:925-931
23. Kristensen JD, Svensson B, Gordh T: The NMDA receptor antagonist CPP abolishes neurogenic "wind up pain" after intrathecal administration in humans. Pain 1992;51:249-253
24. Yang CY, Wong CS, Chang JY et al: Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996;43:379-383
25. Nishiyama T, Gyermek L, Lee C et al: The spinal thermal or formalin-induced pain in rats. Anesth Anal 1999;89:143-147
26. Zahn PK, Umaili E, Brennan TJ: Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain. Pain 1998;74:213-223
27. Yaksh TL: Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22:845-858
28. Kamisaki Y, Hamada T, Maeda K et al: Presynaptic alpha-2 adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. J Neurochem 1993;60:522-526
29. Yaksh TL, Progrel JW, Lee YW et al: Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 1995;272:207-214
30. Eisenach JC, DuPen M, Miguel R et al: Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 1995;61:391-399
31. Rauck RL, Eisenach JC, Jackson K et al: Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993; 79: 1163-1169
32. Coombs DW, Saunders RL, Franklin JD et al: Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. J Neurosurg 1986;64:890-894
33. Middleton JW, Siddall PJ, Walker S et al: Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: A case study. Arch Phys Med Rehabil 1996; 77:824-826
34. Filos KS, Goudas LC, Patroni O et al: Hemodynamics and analgesic profile after intrathecal clonidine in humans. Anesthesiology 1994;81: 591-601
35. Ossipov MH, Lopez Y, Bian D et al: Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury. Anesthesiology 1997;86:196-204
36. Unnerstall JR, Kopajtic TA, Kuhar MJ: Distribution of alpha-2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related androgenic agents. Brain Res 1984;319:69-101
37. Gillberg PG, d'Argy R, Aquilonius SM: Aoto radiographic distribution of [3H]acetylcholine binding sites in the cervical spinal cord of man and some other species. Neurosci Lett 1988;90:197-202
38. Pan HL, Chen SR, Eisenach JC: Intrathecal clonidine alleviates allodynia in neuropathic rats. Anesthesiology 1999;90:509-514
39. Aprison MH, Shank RP, Davidoff RA: A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates. Comp Biochem Physiol 1969;28:1345-1355
40. Rizzoli AA: Distribution of glutamic acid, aspartic acid, gamma-aminobutyric acid and glycine in six areas of cat spinal cord before and after transection. Brain Res 1968;11:11-18
41. B receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci 1989;10:401-406
42. Akagi H, Miledi R: Heterogeneity of glycine receptors and their messenger RNAs in rat brain and spinal cord. Science 1988;242:270-273
43. Monaghan DT, Olverman HJ, Nguyen L et al: Two classes of N-methyl-D-aspartate recognition sites: Differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 1988;85: 9836-9840
44. Beyer C, Banas C, Gonzalez-Flores O et al: Blockage of substance P-induced scratching behavior in rats by the intrathecal administration of inhibitory amino acid agonists. Pharmacol Biochem Behav 1989; 34:491-495
45. A receptors and excitatory amino acids in mouse spinal cord. J Pharmacol Exp Ther 1989;248:1034-1038
46. Nishiyama T, Gyermek L, Lee C et al: Analgesic interaction between intrathecal midazolam and Glutamate receptor antagonists on thermal induced pain in rats. Anesthesiology 1999;91:531-537
47. Hwang JH, Yaksh TL: The effect of spinal GABA receptor agonists on tactile allodynia in a surgically induced neuropathic pain model in the rat. Pain 1997;70:15-22
48. Satoh O, Omote KL: Roles of monoaminergic, glycinergic and GABAergic inhibitory systems in the spinal cord in rats with peripheral mononeuropathy. Brain Res 1996;728:27-36
49. Omote K, Sonoda H: Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology 1993;79:746-752
50. Serrao JM, Marks RL, Morley SJ et al: Intrathecal midazolam for the treatment of chronic mechanical low back pain: A controlled comparison with epidural steroid in a pilot study. Pain 1992;48:5-12
51. Valentine JM, Lyons G, Bellamy MC: The effect of intrathecal midazolam on post operative pain. Eur J Anesthesiol 1996;13:589-593
52. Borg PA, Krijnen HJ: Long-term intrathecal administration of midazolam and clonidine. Clin J Pain 1996;12:63-68
53. Taira T, Tanikawa T, Kawamura H et al: Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry 1994; 57:381-382
54. Penn RD, Savoy SM, Corcos DM et al: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-1521
55. Penn RD. Intrathecal baclofen for spasticity of spinal origin: Seven years of experience. J Neurosurg 1992;6:115-118
56. Albright AL, Ceervi A, Singletary J: Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1993;265:1418-1422
57. Albright AL, Barron WB, Fasick MP et al: Continuous intrathecal baclofen for infusion for spasticity of cerebral origin. JAMA 1993; 270:2475-2477
58. Stewart-Wynne EG, Silbert PL, Buffery S et al: Intrathecal baclofen for severe spasticity: Five years' experience. Clin Exp Neurol 1991; 28:244-245
59. Parke B, Penn RD, Savoy SM et al: Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989;70:30-32
60. Broseta J, Garcia-March G, Sanchez-Ledesma MJ et al: Chronic intrathecal baclofen administration in severe spasticity. Stereotact Funct Neurosurg 1990;55:147-153
61. Armstrong RW, Steinbok P, Farrell K et al: Continuous intrathecal baclofen treatment of severe spasm in two children with spinal cord injury. Dev Med Child Neurol 1992;34:731-738
62. Lynch C, Pancrazio JJ: Snails, spiders and stereospecificity - Is there a role for calcium channels in anesthetic mechanisms? Anesthesiology 1994;81:1-5
63. Brose WG, Cherukuri S, Longton WC et al: Safety and efficacy of intrathecal SNX-111, a novel analgesic, in the management of intractable neuropathic and nociceptive pain in humans. Presented at the American Pain Society Scientific Meeting, Los Angeles, CA, USA, 1995
64. Staats PS, Charapata S, Ferrer-Brechner T et al: Chronic intractable neuropathic pain: Marked analgesic efficacy of ziconotide. Proceeding of the International Neuromodulation Society, Lucerne, Switzerland, September 1998
65. Omote K, Kawamata M, Satoh O et al: Spinal antinociceptive action of a N-type voltage dependent calcium channel blocker and the synergistic interaction with morphine. Anesthesiology 1996;84:636-643
66. Urban L, Willetts J, Murase K et al: Cholinergic effects on spinal dorsal horn neurons in vitro: An intracellular study. Brain Res 1989; 500:12-20
67. Hood DD, Eisenach JC, Tuttle R: Phase 1 safety assessment of intrathecal neostigmine methyl sulfate in humans. Anesthesiology 1995; 82:331-343
68. Bouaziz H, Tong CY, Yoon Y et al: Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn - systemic studies in sheep and an observation in a human. Anesthesiology 1996;84:143-145
69. Eisenach JC, Detweiler DJ, Tong CY et al: Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 1996;82:621-626
70. Naguib M, Yaksh TL: Antinociceptive effects of spinal cholinesterase inhibition and isobolo-graphic analysis of the interaction with mu and alpha-2 receptor systems. Anesthesiology 1994;80:1338-1348
71. Lauretti GR, Reis MP, Prado WA et al: Dose dependent study of intrathecal morphine vs intrathecal neostigmine, their combination, or placebo for post-operative analgesia in patients undergoing anterior and posterior vaginoplasty. Anesth Analg 1996;82:1182-1187
72. Klamt JG, Dos Reis MP, Neto JB et al: Analgesic effect of subarachnoid neostigmine in two patients with cancer pain. Pain 1996;66:389-391
73. Bouaziz H, Tong C, Eisenach JC: Post-operative analgesia from intrathecal neostigmine in sheep. Anesth Analg 1995;80:1140-1144
74. Gillberg PG, Gordh T Jr, Hartvig P et al: Characterization of the antinociception induced by intrathecally administered carbachol. Pharmacol Toxicol 1989;64:340-343
75. Bannon AW, Decker MW, Holladay MW et al: Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 1998;279:77-81
76. Lauretti GR, Azevedo VMS: Intravenous ketamine or fentanyl prolongs postoperative analgesia after intrathecal neostigmine. Anesth Analg 1996;83:766-770
77. Lauretti GR, Mattos AL, Reis MP et al: Intrathecal neostigmine for postoperative analgesia after orthopedic surgery. J Clin Anesth 1997; 9:473-477
78. Carp H, Jayaram A, Morrow D: Intrathecal cholinergic agonists lessen bupivacaine spinal block induced hypotension in rats. Anesth Analg 1994;79:112-116
79. Rose G, Xu ZM, Tong CY et al: Spinal neostigmine diminishes, but does not abolish, hypotension from spinal bupivacaine in sheep. Anesth Analg 1996;83:1041-1045
80. Hood DD, Mallak KA, Eisenach JC et al: Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. Anesthesiology 1996;85:315-325
81. Nelson KE, D'Angelo R, Foss ML et al: Intrathecal neostigmine and sufentanil for early labor analgesia. Anesthesiology 1999;91:1293-1298
82. Daly JW: Adenosine receptors: Targets for future drugs. J Med Chem 1982;25:197-207
83. Fredholm BB: Adenosine receptors in the central nervous system. News Physiol Sci 1995;10:122-128
84. Holmgen M, Hedner J, Mellstrand T et al: Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn Schmiedebergs Arch Pharmacol 1986;334:290-293
85. Karlston R, Gordh T, Hartwig P et al: Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 1990;71:60-64
86. Reeve AJ, Dickenson AH: The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neuronsin the anaesthetized rat. Br J Pharmacol 1995;116: 2221-2228
87. Sjolund K-F, Sollevi A, Segerdahl M et al: Intrathecal and systemic R-phenylisopropyladenosine reduces scratching behavior in a rat mononeuropathy model. NeuroReport 1996;7:1856-1860
88. Sjolund K-F, Sollevi A, Sgerdahl M et al: Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats. Anesth Analg 1997;85:627-632
89. Cui J-G, Sollevi A, Lindroth B et al: Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci Lett 1997;223:173-176
90. Lindblom U, Nordfors L-O, Sollevi A et al: Adenosine for pain relief in a patient with intractable secondary erythromelalgia. Eur J Pain 1997;1;229-302
91. Karlston R, Gordh T: An A 1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995;80:844-847
92. Rane K, Segerdahl M, Goiny M et al: Intrathecal adenosine administration. Anesthesiology 1998;89:1108-1115
93. Terenghi G, Riveros-Moreno V, Hudson LD et al: Immunohistochemistry of nitric oxide synthase demonstrates immunoreactive neurons in spinal cord and dorsal root ganglia of man and rat. J Neurol Sci 1993;118:34-37
94. Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993;52;127-136
95. 2 release after carrageenan/ kaolin-induced knee joint inflammation. A chronic microdialysis study. Pain 1996;67:345-354
96. Meller ST, Cummings CP, Traub RJ et al: The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994;60: 367-374
97. Song HK, Pan HL, Eisenach JC: Spinal nitric oxide mediates antinociception from iv morphine. Anesthesiology 1998;89:215-221
98. Kolesnikov YA, Pan YX, Babey AM et al: Functionally differentiating two neuronal nitric oxide synthase through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 1997;94:8220-8225
99. Yaksh TL, Pogrel JW, Lee YW et al: Reversal of nerve ligation induced allodynia by spinal alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 1995;272:207-214
100. Xu ZM, Tong C, Pan HL et al: Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-2 adrenergic and cholinergic mechanism. J Neurophysiol 1997;78:2072-2078
101. Pan HL, Chen SR, Eisenach JC: Role of spinal NO in antiallodynic effects in intrathecal clonidine in neuropathic rats. Anesthesiology 1998;89:1518-1523
102. Kawabata A, Nishimura Y, Takagi H: L-Leucyl-L-arginine, naltrindole, and D-arginine block antinociception elicited by L-arginine in mice with carrageenin induced hyperalgesia. Br J Pharmacol 1992; 1071:1096-1101
103. Kamei J, Iwamoto Y, Misawa M et al: Antinociceptive effect of L-arginine in diabetic mice. Eur J Pharmacol 1994;254:113-117
104. Willis WD, Coggeshall RE: Sensory Mechanisms of the Spinal Cord. New York, Plenum Press, 1991, p 485
105. DeLander GE, Hopkins CJ: Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacology 1987;26:1791-1794
106. Basbaum A: Anatomic substrates for descending control of nociception. In Sjolund B, Bjorklund A (eds): Brain Stem Control of Spinal Mechanisms. Amsterdam, Elsevier Biomedical Press, 1982, pp 119-133
107. Fozard JR: 5-HT:The enigma variations. Trends Pharmacol Sci 1987; 8:501-506
108. 2 receptor subtypes in modulating behavior induced by excitatory amino acid receptor agonists in mice. Brain Res 1993;626:78-82
109. Richardson BP, Engel G, Donatsch P et al: Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985;316:126-131
110. Fields HL, Heinricher MM, Mason P: Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991;14:219-245
111. Eisenach JC, Gebhart GF: Intrathecal amitriptyline-antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine and carbamylcholine in rats. Anesthesiology 1995;83:1036-1045
112. Eisenach JC, Gebhart GF: Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995;83:1046-1054
113. Haley JE, Sullivan AF, Dickenson AH: Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990;518:218-226
114. Davar G, Hama A, Deykin A et al: MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1991;553:327-330
115. Simone DA, Sorkin LS, Oh U et al: Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 1991;66:228-246
116. Sernagor E, Kuhn D, Vyklicky L Jr et al: Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron 989;2:1221-1227
117. ++ levels in neuronal culture. Eur J Pharmacol 1992;219:53-57
118. Reynolds IJ, Miller RJ: Tricyclic antidepressants block N-methyl-D-aspartate receptors: Similarities to the action of zinc. Br J Pharmacol 1998;95:95-102
119. Mjellum N, Lund A, Hole K: Reduction of NMDA induced behavior after acute and chronic administration of Desipramine in rats. Neuropharmacology 1993;32:591-595
120. Cerda SE, Tong C, Deal DD et al: A physiologic assessment of intrathecal amitriptyline in sheep. Anesthesiology 1997;86:1094-1103
121. Flett SR, Szabadi E, Bradshaw CM: A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers. Eur J Clin Pharmacol 1992;42:529-533
122. Low PA, Opfer-Gehrking TL: Differential aspects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects. Muscle Nerve 1992;15:1340-1344
123. Bourne M, Szabadi E, Bradshaw CM: A comparison of the effects of single doses of amoxapine and amitriptyline on autonomic function in healthy volunteers. Eur J Clin Pharmacol 1993;44:57-62
124. Dirksen R, Van Diejen D, Van Luijtelaar ELJM et al: Site and test dependent antinociceptive efficacy of amitriptyline in rats. Pharmacol Biochem Behav 1994;47:21-26
125. Ryall WL: Effects of monoamines upon sympathetic preganglionic neurons. Circ Res 1967;20,21 (Suppl III):83-87
126. Bhargava KP, Pant KK, Tangri KK: Cholinergic influences on the spinal cardiovascular neurons. J Auton Pharmacol 1982;2:225-230
127. Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993;79:270-281
128. Eisenach JC: Aspirin, the miracle drug: Spinally, too? Anesthesiology 1993;79:211-213
129. Poddubiuk ZM, Kleinrok Z: A comparison of the central actions of prostaglandins A2, E1, E2, F1 and F2 in the rat. Psychopharmacology 1976;50:95-102
130. Parris WC, Janicki PK, Johnson B Jr et al: Intrathecal tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat. Can J Anesth 1996;43:867-870
131. Yamamoto T, Sakashita Y: COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA. NeuroReport 1998;9:3869-3873
132. Garces YI, Rabito SF, Minshall RD et al: Lack of potent antinociceptive activity by substance-P antagonist CP-96, 345 in the rat spinal cord. Life Sci 1993;52:353-360
133. Misterek K, Maszczynska I, Dorociak A et al: Spinal co-administration of peptide Substance P antagonist increases antinociceptive effect of the opioid peptide biphalin. Life Sci 1994;54:939-944
134. 8-37 increases the latency to withdrawal responses in rats. Brain Res 1994;223-230
135. Terenius L: Somatostatin and ACTH are peptides with partial antagonist like selectivity for opiate receptors. Eur J Pharmacol 1976; 38:211-213
136. Mollenholt P, Rawal N, Gordh T Jr: Intrathecal and epidural somatostatin for patients with cancer. Anesthesiology 1994;81:534-542
137. Paice JA, Penn RD, Kroin JS: Intrathecal octreotide for relief of intractable non-malignant pain: 5 year experience with two cases. Neurosurgery 1996;38:203-207
138. Langerman L, Golomb E, Benita S: Significant prolongation of the pharmacologic effect of tetracaine using a lipid solution of the agent. Anesthesiology 1991;74:105-107
139. Langerman L, Golomb E, Benita S: Prolongation of the pharmacologic effect of meperidine by the use of a lipid solution of it. Anesthesiology 1991;72:635-638
140. Masters DB, Berde CB, Datta S et al: Sustained local anesthetic release from bioerodible polymer matrices: A potential method for prolonged regional analgesia. Pharm Res 1993;10:1527-1532
141. Sato S, Baba Y, Tajima K et al: Prolongation of epidural anesthesia in the rabbit with the use of a biodegradable copolymer paste containing lidocaine. Anesth Analg 1995;80:97-101
142. Lesser GJ, Grossman SA, Leong KW et al: In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain 1996;65:265-272
143. Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain. to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69
144. Cobbold SP, Martin G, Qin S et al: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164-166
145. Livett BG, Dean DM, Whelan LG et al: Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 1981; 289:317-319
146. Wilson SP, Chang KJ, Viveros OH: Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture. J Neurosci 1982;2:1150-1156
147. Wu HH, Lester BR, Sun Z et al: Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain 1994;56:203-210
148. Sagen J, Pappas GD, Pollard HB: Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci USA 1986;83:7522-7526
149. Sagen J, Wang H, Pappas GD: Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain 1990; 42:69-79
150. Winnie AP, Pappas GD, Das Gupta TK et al: Subarachnoid adrenal medullary transplants for terminal cancer pain. Anesthesiology 1993; 79:644-653
151. Staats PS, Dougherty P: Intraspinal pharmacology. In Raj PP (ed): Practical Management of Pain, ed 3. St. Louis, Mosby Year Book, 2000 (in press)